Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-07-18

FDA Approved: CLONAZEPAM — Supplemental Application (Advagen Pharma Ltd)

View source ↗

Summary

The FDA approved a supplemental application for clonazepam submitted by Advagen Pharma Ltd.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clonazepam (Clonazepam)

Snippet

SUPPL AP for CLONAZEPAM (CLONAZEPAM)